Stock & Company Details
Genelux Corp $GNLX
Price:
N/A
N/A
45M
$113M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.94
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GNLX technical indicators
Latest Genelux Corp (GNLX) indicator readings as of 2026-10-09.
GNLX's 14-day RSI is 50.8, in neutral territory. At $2.56 it is trading 8.5% below its 200-day moving average of $2.80, and below its 50-day average of $2.60. Price sits in the middle of its Bollinger Bands ($2.39 to $2.63). ADX reads 10.6, indicating a range-bound market rather than a trend.
Overview
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Finance Bot
Ask your questions
Start by typing a question below.
